Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Ameloblastoma
Research findings from University of Ferrara update understanding of ameloblastoma
April 1st, 2008
"We performed an immunohistochemical study in a series of ameloblastomas with different histology to explore the existence of a correlation between CD10 immunoreactivity in peritumoral stromal cells and the type of ameloblastoma with a high risk of local recurrence. A total of 45 ameloblastomas ( 18 unicystic [ UA], 4 peripheral [ PA], 23 solid/ multicystic [ SA]) were evaluated," researchers in Ferrara, Italy report. "Cases showing immunoreactivity for CD10 in < and >= 10% of stromal cells around tumoral epithelial islands, were considered, respectively, negative and positive. Correlations between stromal CD10 expression and histopathologic types with low and...
Source: Cancer Weekly (2008-04-01)
|
